Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer
Clinical trial NCT01234337 · COMPLETED
Trial details
- NCT number
- NCT01234337
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-21
- Primary completion
- 2014-05-12
- Enrollment
- 537
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.